Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab
Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
This study is a retrospective cohort study. A database will be created from the data
available of all patients that have participate in the named patient program for
pembrolizumab in the Netherlands. This database will be used for analysis of response markers
and for an evaluation of adverse events.